Research library
Sources, with the status on the record.
Each row is a paper or a ClinicalTrials.gov entry checked on 21 November 2026. Titles are the authors’ or the registry’s words. Nalen Lab does not restate them as claims about these products. A registration is not a result.
Records checked 2026-11-21. Open registry rows in this view: 0. Selank has published papers and no verified intervention trial.
Loading filters…
Selank
2017
Publication
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.
Kasian A et al. · Behavioural Neurology
PublishedSame compound as the catalogue listing
Rat study. The title is the authors' wording.
View in the catalogueSelank
2019
Publication
Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
Kolik LG et al. · Bulletin of Experimental Biology and Medicine
PublishedSame compound as the catalogue listing
Rat study.
View in the catalogueSelank
2020
Publication
Functional Connectomic Approach to Studying Selank and Semax Effects.
Panikratova YR et al. · Doklady Biological Sciences
PublishedSame compound as the catalogue listing
The paper also discusses Semax, which is not in the Nalen Lab catalogue.
View in the catalogue